TRT(SH:600085) Mei Ri Jing Ji Xin Wen·2025-12-16 01:58Core Viewpoint - On December 15, Beijing Tongrentang Health Industry Co., Ltd. announced that it has ordered its subsidiary, Sichuan Tongrentang Health Industry Co., Ltd., to stop distributing the "99% High Purity Antarctic Krill Oil" product due to allegations of false labeling of its ingredients, and has initiated legal proceedings against the involved companies [1][9]. Group 1: Company Actions and Responses - The company has launched a full-process investigation and traceability for the disputed product, which was found to have falsely used the "Beijing Tongrentang" name without authorization [1][9]. - The Shanghai Consumer Protection Commission has announced plans to interview the production company, Anhui Habao Pharmaceutical Co., Ltd., and the distributor, Sichuan Tongrentang Health Industry, to clarify the product's actual situation [9]. - The company has advised consumers to purchase "Beijing Tongrentang" products only through official channels and to recognize the "Double Dragon" trademark to avoid potential losses [9]. Group 2: Brand and Market Context - The Tongrentang brand has faced multiple disputes regarding authenticity, including trademark infringement cases involving three recognized Tongrentang brands: Beijing Tongrentang, Tianjin Tongrentang, and Nanjing Tongrentang [10][11]. - The internal structure of Tongrentang Group is complex, with three listed companies under its umbrella, and it has been involved in previous controversies, such as the 2018 case where a subsidiary was fined over 14 million yuan for using expired honey [6][10]. - Despite efforts to unify the three Tongrentang brands, the ownership structure remains fragmented, with Beijing Tongrentang Group controlled by the Beijing State-owned Assets Supervision and Administration Commission, while Nanjing Tongrentang is controlled by the Qingdao State-owned Assets Supervision and Administration Commission [11].